According to GlobeNewswire, the crypto fintech company Antalpha, which focuses on serving Bitcoin mining enterprises, announced the pricing of its initial public offering at $12.80 per share, issuing 3.85 million shares of common stock under the ticker symbol "ANTA", and began trading today on the Nasdaq Global Market. The IPO is expected to raise approximately $49.3 million, with a maximum of $56.7 million if the over-allotment option is exercised. The proceeds will be used for product development, global expansion, customer financing support, and investment in Bitcoin and digital gold, among other purposes.
Antalpha to be listed on Nasdaq, IPO priced at $12.80 aiming to raise nearly $50 million
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks
Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.
